Pharmacolog invests in direct sales
Pharmacolog chooses to adjust its current sales strategy to invest more in direct sales resources via its own subsidiaries and strategic partnerships. The company has previously announced that it has terminated the cooperation with Pharmed SAM and establishing its own company in France. One consequence of the changed strategy is that the current sales manager leaves the company.The company has decided to partially change its current sales strategy to invest more in direct sales resources in its key markets in the US and France. One consequence of this is that the company now forms its own